
Louisiana researchers probe how GLP-1 weight‑loss drugs reshape metabolism
Louisiana researchers at Pennington Biomedical Center, led by Dr. Eric Ravussin, are studying how GLP-1 weight‑loss drugs affect metabolism and muscle mass, including resting metabolic rate and energy expenditure in a metabolic chamber to understand metabolic adaptation that can slow weight loss, while clinicians emphasize adequate protein and exercise to minimize muscle loss as these therapies evolve.


